POR ALEJANDRO LUNA Y JUAN LUIS SERRANO LIFE SCIENCE IP FOCUS, 8TH EDITION, MANAGING INTELLECTUAL PROPERTY 2010 MEXICO’S DRUG REGULATORS ARE PREPARING TO ISSUE NEW RULES ON BIOCOMPARABLE DRUGS. Mexico’s General Health Law was reformed on June 11 2009 in ways that will have an important impact on patent owners within the pharmaceutical and life sciences industries.[...]

POR ROMMY MORALES INTERNATIONAL BRIEFINGS, MANAGING INTELLECTUAL PROPERTY, SEPTEMBER 2010 Article 19, section VII of the Mexican Industrial Property Law establishes, inter alia, that methods of therapeutic treatment applicable to the human body and to animals shall not be considered as inventions; as a result, such methods are expressly excluded from patentability. However, under Mexican law and[...]

BY GEORGINA FLORES In order to update the means of receiving documentation, the Mexican Patent Office (IMPI) has amended the Rules for filing applications by means of an Act published on March 18 2010 in the Official Gazette. The Act is effective from the following day. Relevant issues in this Act include those referred to in[...]

BY OSVALDO AMARAL, MANAGING INTELLECTUAL PROPERTY, MARCH 2005 GIVEN THE RICHNESS OF MEXICO’S GENETIC RESOURCES, BIOPIRACY IS A SERIOUS THREAT IN THE COUNTRY. Mexico has the world’s fourth most biologically diverse eco-system: every existing biome can be found in the country. The country also contains 34 of 36 identifiable eco-climates and 25 out of 28 categories[...]

BY GEORGINA FLORES MANAGING INTELLECTUAL PROPERTY, INTERNATIONAL BRIEFINGS, SEPTEMBER 2008 In recent months, the Mexican Patent Office (IMPI) has changed its practice regarding the time limit to file divisional applications. In cases where divisional applications are filed as a result of a requirement regarding lack of unity of the invention, they must be filed simultaneously with[...]

BY ERWIN CRUZ SALDÍVAR Last April, the Mexican Congress approved amendments to the IP Law related mainly to patent practice. These amendments are pending ratification by the Presidential Office and publication in the Official Gazette. The original project of reform promoted by the generic medicines industry aimed, among other issues, to insert two separate pre- and[...]

BY OSVALDO AMARAL MANAGING INTELLECTUAL PROPERTY, INTERNATIONAL BRIEFINGS, OCTOBER 2007 When it comes to prosecuting a patent application before the Mexican Patent Office, the applicant should remember that the Office does not undertake a completely independent substantive examination of patent applications. Mexico’s Law of Industrial Property contemplates that the Office may accept or require the findings[...]